[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heart-failure-with-preserved-ejection-fraction-hfpef-diagnosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heart-failure-with-preserved-ejection-fraction-hfpef-diagnosis":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100597359","prospective-evaluation-of-ai-ecg-for-shd-detection-100597359",false,"NCT07057466","Prospective Evaluation of AI-ECG for SHD Detection","Prospective Evaluation of Artificial Intelligence-enhanced Electrocardiography for Detection of Structural Heart Disease","AI-ECG-SHD","Inclusion Criteria:\n\n* Patients aged 18-90 years\n* No prior formal diagnosis of HF (including systolic and diastolic dysfunction), PH, or VHD\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Severe arrhythmia or unstable cardiovascular disease\n* Prior formal diagnosis of HF (including systolic and diastolic dysfunction), PH, or VHD\n* Cardiac implantable electronic device in-situ, including a permanent pacemaker or implantable cardioverter defibrillator\n* Involvement in current research or recent involvement in any research prior to recruitment",true,"ALL","18 Years","90 Years",{"count":22,"type":23},590,"ESTIMATED","OBSERVATIONAL","This study aims to improve the early detection of undiagnosed heart disease, which causes serious health issues, hospital admissions, and high healthcare costs. Researchers are exploring how artificial intelligence (AI) can analyse routine heart tests, called electrocardiograms (ECGs), to detect heart problems. These tests can be done using both traditional ECG machines and portable, wearable devices like smartwatches, making it easier for people to monitor their heart health at home.\n\nWhile AI has shown promise using past data, this study will involve the collection of ECG data and subsequent testing of its accuracy in real-world settings to ensure it works well for both doctors and patients. The goal is to see if AI can identify conditions like heart muscle weakness, valve issues, and high lung pressure from the ECG data of patients. The researchers will also compare AI's detections with other blood tests commonly used to diagnose heart disease.\n\nThe AI models that will be used are being tested for research and validation purposes only. They will not be used for clinical decision-making or providing information to influence diagnosis, treatment, or patient care during the study. The AI outputs are not shared with clinicians and will have no impact on the care pathway.\n\nThis research will demonstrate if AI-powered ECG analysis - whether from traditional or portable devices - can provide a low-cost, non-invasive way to detect heart disease early and improve health assessments.",[27,28,29,30],"Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)","Pulmonary Hypertension (Diagnosis)","Heart Failure With Reduced Ejection Fraction (HFrEF; Diagnosis)","Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)",[32,33,34,35,36,37,38,39,40],"Artificial Intelligence","Machine Learning","Wearable Devices","Portable Devices","Heart Failure","Pulmonary Hypertension","Valvular Heart Disease","Echocardiography","Electrocardiography","RECRUITING","2026-03-06",{"date":44,"type":45},"2026-03-09","ACTUAL",{"date":47,"type":45},"2025-11-04",{"date":49,"type":23},"2027-08-02",{"name":51,"class":52},"Imperial College London","OTHER",5,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":18,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":5},"100621808","heart-failure-with-preserved-ejection-fraction-in-patients-with-hronic-obstructive-pulmonary-disease-clinical-course-and-prognosis-100621808","NCT07375433","Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course and Prognosis","HIPSTER","Inclusion Criteria:\n\n1. Verified diagnosis of COPD;\n2. Patients hospitalized with COPD;\n3. Citizenship of the Russian Federation;\n4. Patients aged 50 to 70 years;\n5. Patient consent to participate in the study.\n\nExclusion Criteria:\n\n1. Lack of Russian Federaion citizenship;\n2. Patient's refusal to participate in the study;\n3. Any chronic diseases, other than COPD, that affect the prognosis, in the acute and\u002For decompensated stage;\n4. Mental disorders.","50 Years","70 Years",{"count":64,"type":23},200,"Study aim is comparison of heart failire with preserved ejection fraction (HFpEF) detection rate in patients with Сhronic Obstructive Pulmonary Disease (COPD) and the clinical course and prognosis in patients with COPD depending on HFpEF presence.",[67,30],"COPD (Chronic Obstructive Pulmonary Disease)",[69,70,71,72,73],"Heart failure","Heart failure with Preserved Ejection Fraction","Biomarkers","COPD","Prognosis","2026-02-07",{"date":76,"type":45},"2026-02-10",{"date":78,"type":45},"2026-01-01",{"date":80,"type":23},"2026-12-31",{"name":82,"class":83},"National Medical Research Center for Therapy and Preventive Medicine","OTHER_GOV"]